The company’s key project is PANURI – pancreatic cancer test. A research experiment involving humans has been completed, confirming high sensitivity and specificity of the test. The second project of Urteste is the MULTI-CANCER project.

MULTI-CANCER represents a diverse portfolio of Urteste’s research projects. The company is dedicated to developing tests for dozens of the most common cancers. Currently, Urteste has 12 prototype diagnostic tests for the following types of cancer: brain, breast, stomach, bile ducts, ovary, uterine corpus, kidney, colorectal, lung, liver, pancreas, and prostate, which collectively account for nearly 70% of all cancer deaths worldwide.